SBIR/STTR Research Award

Design of a real-time dosimetry prototype for use with external beam radiotherapy

Award identifier 562f0d7c9618c82b51f64a39a4e18c87ac71179f5a6f1807db066f285e417091Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$149,800

Program and phase

STTR · Phase I

Award year

2012

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Best Medical International, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
FR48HKRTDPX3
Solicitation number
PA12-089
Topic code
NCI

Research abstract

DESCRIPTION (provided by applicant): Radiation oncology patients receive highly complicated treatments such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy, stereotactic radiosurgery and stereotactic body radiation therapy using clinical linear accelerators. Currently, the quality assurance (QA) of a radiation treatment is don a priori to measure cumulative doses, which is not sensitive to temporal beam modulation. Therefore, the actual quality and safety of the deliveredtreatment is unknown and patient mistreatment cannot be identified or corrected. We hypothesize that if in vivo real time on line transmission detectors for external beam radiotherapy are developed, radiotherapy accidents will be prevented to achieve considerable improvement in treatment accuracy, verification, recording, and efficacy. This proposal addresses the urgent need for in vivo real time transmission detectors to provide radiation oncology clinics a novel treatment verification and control paradigm. These online, all time detectors will increase patient safety during treatment by improving external beam delivery accuracy, providing real time treatment verification, real time detection of departures from planned treatments, automatic beam halting andwarnings if errors are detected, automatic QA procedures and standardization, and true determination of the spatial and temporal fluence delivered to the patient by each IMRT beam. The impact of this enhancement will improve external beam radiotherapy safety and treatment accuracy, which will improve the treatment outcome for 50% of cancer patients. In our clinic alone, this number is estimated to be 270 patients per day. In a consortium between Washington University in Saint Louis and Best Medical Int., we will develop an in vivo real time transmission detector for external beam radiotherapy using highly integrated plastic encapsulated radiation hard scintillating fibers and monolithic high gain photosensors. The high throughput electronics of the detectorare constructed using parallel data conversion and parallel data acquisition integrated circuits. This fast and parallel electronic interface is capable of detecting treatment errors durig delivery in real time and accordingly correct or suspend a treatment if patient health is compromised. The commercially viable detector prototype will be validated using external beam QA and anthropomorphic phantoms, delivering treatment plans for head and neck and lung cancer and formulating patient QA protocols based on real time treatment verification of these two cancer sites. The proposed imaging dosimeter can be applied to real time verification of other cancer malignancies and treatments, but in this project we will concentrate on these two sites as models and validation for the implementation of this technology to enhance the safety and therapeutic efficacy of external beam radiotherapy in current clinical practice. The low cost and autonomous capability of the proposed technology makes its implementation simple and adaptable for large and small clinical operations. PUBLIC HEALTH RELEVANCE: We propose the development of a novel in vivo real time transmission detector for external beam radiotherapy and software tools to foster the advancement of external beam intensity modulated treatment delivery quality assurance and patient safety. Our technology will allow, for the first time, the in vivo and real time measuremen of the true fluence delivered to a patient during intensity modulated radiotherapy treatment. The technology is based on low cost scintillating fiber array detectors coupled to monolithic photosensors, parallel data acquisition for fast data analysis and processing, and high speed hardware implemented algorithms for treatment verification and patient safety. Validation of this technology to enhance the safety and efficacy of external beam treatment of head and neck and lung cancer will be studied to demonstrate the implementation of this technology in today's clinical external beam megavoltage radiotherapy practice.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2011–2012). Reported award amounts total $265,768. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.